REQUEST A DEMO
Total
USD $0.00
Search more companies

Hemofarm OOO (Хемофарм ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Hemofarm OOO Profile Updated: October 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Hemofarm OOO (Хемофарм ООО) is based in Russia. The head office is in Obninsk. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on December 29, 2018. It currently has a total number of 209 (2023) employees. From the latest financial highlights, Hemofarm OOO (Хемофарм ООО) reported a net sales revenue increase of 41.26% in 2024. Its’ total assets recorded a growth of 1.13%. In 2024, Hemofarm OOO (Хемофарм ООО)’s net profit margin increased by 0.88%.

Headquarters
Kievskoe, 62
Obninsk; Kaluga Oblast; Postal Code: 249035

Contact Details: Purchase the Hemofarm OOO (Хемофарм ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Hemofarm OOO (Хемофарм ООО) report to view the information.
Registered Capital:
Purchase the Hemofarm OOO (Хемофарм ООО) report to view the information.
Financial Auditors:
Purchase the Hemofarm OOO (Хемофарм ООО) report to view the information.
Incorporation Date:
December 29, 2018
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hemofarm OOO (Хемофарм ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
41.26%
Total operating revenue
41.26%
Operating profit (EBIT)
413.22%
Net Profit (Loss) for the Period
240.65%
Total assets
1.13%
Total equity
0.39%
Operating Profit Margin (ROS)
6.2%
Net Profit Margin
0.88%
Return on Equity (ROE)
0.28%
Quick Ratio
-1.02%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?